Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-012076
Filing Date
2019-08-12
Accepted
2019-08-12 16:26:55
Documents
1
Period of Report
2019-08-12
Effectiveness Date
2019-08-12

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 384298
  Complete submission text file 0001493152-19-012076.txt   385634
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51353 | Film No.: 191016843
SIC: 7389 Services-Business Services, NEC